|
" Acute Leukemias IV Prognostic Factors and Treatment Strategies "
T Büchner
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
724483
|
| Doc. No
|
:
|
b544202
|
| Main Entry
|
:
|
T Büchner
|
| Title & Author
|
:
|
Acute Leukemias IV Prognostic Factors and Treatment Strategies\ T Büchner
|
| Publication Statement
|
:
|
Berlin Springer Berlin, 2013
|
| Series Statement
|
:
|
Haematology and Blood Transfusion /Hämatologie und Bluttransfusion, 36
|
| Page. NO
|
:
|
XXXVI, 803 Seiten in 1 Teil XXXVI, 803 Seiten 320 Figuren, 286 tables, 286 schw.-w. Tabellen 235 x 155 mm
|
| ISBN
|
:
|
364278352X
|
|
|
:
|
: 9783642783524
|
| Contents
|
:
|
The Treatment of Acute Leukemia: Observations by a Marrow Transplanter.- Leukemia Cell Biology.- Polymerase Chain Reaction Approach for the Evaluation of Minimal Residual Disease in Acute Leukemia.- Two Subtypes of Therapy-Related Leukemia; Experience from The Copenhagen Series.- Incidence, Biologic Features and Treatment Outcome of Myeloid-Antigen-Positive Acute Lymphoblastic Leukemia (My + ALL).- In Situ Amplification of Rearranged Gene Sequences in Individual Cells for Tracing Clonal Cells in Smears from Blood and Bone Marrow.- Detection of Chromosomal Abnormalities on Previously Stained Peripheral Blood and Bone Marrow Smears.- Interphase Cytogenetics of Childhood Acute Lymphoblastic Leukemia with Fluorescence In Situ Hybridization Using a Panel of Eight Chromosome-Specific DNA Probes.- Identification and Characterization of Monoclonal Lymphoid Populations by Analysis of Complementary RNA of Clone-specific DNA Sequences.- Differences in Immunoglobulin and T-Cell Receptor Gene Rearrangement Patterns in Acute Lymphoblastic Leukemia Between Diagnosis and Relapse.- Characterization of Clonal Gene Rearrangements for the Detection of Residual Leukemic Disease in Acute Lymphoblastic Leukemia.- Analysis of Variable Number of Tandem Repeats Reveals Differences Between Leukemic Cells and Remission Phase Leukocytes.- The tal-1 Gene Rearrangement in Acute Lymphoblastic Leukemia.- Significance of Lineage-Associated Transcripts of TdT and ETS1 for Detection of Leukemic Cells.- Mutations of the P53 Gene in Acute Leukemias: A Report on 207 Cases.- Regulation of the Expression of ICAM-1 on Pre-B Cell Lines by TNF-? and IFN-?.- Modulation of Adhesion Molecules in Patients with AML During Immunotherapy with IL-2.- Frequency of Aberrant Surface Marker Expression in 221 Cases of Adult Acute Leukemia: An Immunologic/Cytogenetic Analysis.- Elevated Plasma Neuropeptide Y as a Marker of B Cell Precursor Leukemia in Children.- Clinical Applications of Stromal Cell Studies in Acute Leukemia.- Effects of TNF? on AML Cells Determined by Flow Cytometric Technique Based on Bromodeoxyuridine Incorporation.- In Vitro Isolation of Human Cytotoxic Clones Specific for Autologous Leukemic Blasts.- Lymphocyte Subsets and IL-1 Production in Children with Acute Lymphoblastic Leukemia During Intensive Chemo- and Radiotherapy.- Novel Therapeutic Approaches.- Treatment Strategy of Acute Promyelocytic Leukemia Using All Trans Retinoic Acid.- Modulation of Ara-C Metabolism by Fludarabine: Therapy for Acute Myelogenous Leukemia.- GM-CSF in Chemotherapy for Newly Diagnosed AML: Multiple Course Priming and Longterm Administration Compared to Chemotherapy Alone.- Etoposide: Update of Clinical Experiences.- Pharmacokinetic Aspects of Etoposide Therapy - A Review.- Clinical Pharmacokinetics of VP-16 - Special Aspects in Children.- DEXA-BEAM Salvage Chemotherapy and High-Dose Chemotherapy Followed by Autologous Bone Marrow Transplantation in Hodgkin's Disease.- Chronic Etoposide Schedules in the Treatment of Non-Hodgkin's Lymphoma.- Etoposide (VP-16) Disposition in Children with Acute Myeloblastic Leukemia.- Myeloablative Regimens Containing High Dose Etoposide Followed by Allogeneic or Autologous Bone Marrow Transplantation for Hematologic Malignancies.- Hematopoietic Growth Factors: New Aspects for Leukemia Treatment.- Effects on Ara-C Cytotoxicity for AML Colony Forming Cells By Priming With rhGM-CSF and rhIL-3 In Vitro and In Vivo.- Myelodysplastic Syndromes: Treatment Indication and Choice of Therapy.- Autologous Bone Marrow Transplantation for Lymphoid Malignancies: The Use of Hematopoietic Growth Factors.- Mitoxantrone: Impact on the Treatment of Leukemias and Lymphomas.- Long-Term Results on Mitoxantrone Treatment in Patients with Low-Grade Non-Hodgkin's Lymphomas.- Comparison of Prednimustine/Mitoxantrone (PmM) and Cyclophosphamide/Vincristine/Prednisolone (COP) in Patients with Low-Grade Non-Hodgkin Lymphomas Followed by Interferon ? Maintenance.- Mitoxantrone, Etoposide and Cytarabine in the Treatment of Acute Myelocytic Leukemia (AML).- Mitoxantrone Pharmacokinetics.- Improving the Remission Quality in Acute Myelogenous Leukemia (AML) by Increasing Cytoreduction During Induction Therapy.- Treatment of Relapsed and Refractory AML with Mitoxantrone and Etoposide: A Study of the Eastern Cooperative Oncology Group.- Pharmacokinetics.- Vitamin A Does Not Enhance the Antileukemic Effect of Vincristine, Daunorubicin, and 6-Thioguanine in Acute Lymphoblastic Leukemia Cells.- Reversal of Multidrug Resistance by R-Verapamil.- Multidrug Resistance in Myelodysplastic Syndromes and Acute Leukemia.- Combinations of Cytostatic Drugs with Calcium/Calmodulin Antagonists for Reversal of Multidrug Resistance.- Modulation of Intracellular Ara-C Metabolism in AML Blasts by GM-CSF.- Clinical Relevance of the Influence of Etoposide on Ara-CTP Formation in Leukemic Blast Cells.- Resistance to Cytosine Arabinoside: Are Mutations in CTP Synthetase an Important Mechanism?.- Inhibitory Effect of 2?,2? -Difluorodeoxycytidine on Cytidine 5?-Triphosphate Synthetase.- Antileukemic Activity In Vitro of Mitoxantrone and Anthracyclines in Untreated Childhood Acute Lymphoblastic Leukemia.- Childhood Acute Lymphoblastic Leukemia and Acute Non-Lymphoblastic Leukemia: Differences in Cellular Drug Resistance, with Emphasis on Glucocorticoids - A Pilot Study.- Cytostatic Drug Resistance in Childhood Relapsed Acute Lymphoblastic Leukemia.- Comparison of Vincristine Pharmacokinetics in Children and Adults.- Molecular Pathways of Topoisomerase II Regulation and Consequences for Chemotherapy.- ALL in Children.- Current Treatment and Results of St. Jude Studies for Childhood Acute Lymphoblastic Leukemia.- Central Nervous System Prophylaxis with High Dose Methotrexate, A Pharmacokinetic and Clinical Study: Results of Protocol FRALLE 89.- Clinical Relevance of Chromosomal Aberrations in Childhood ALL: Cytogenetic Data of the German Therapy Studies.- Overview of Dana Farber Cancer Institute-Consortium Childhood Acute Lymphoblastic Leukemia Protocols: 1973-1992.- Results with Randomized BFM Adopted Studies for ALL Therapy in Childhood in East German Countries.- Dose Intensity and Prognosis in Acute Lymphocytic Leukemia of Childhood.- Intensive Chemotherapy for Acute Leukaemias (AL) in Childhood with BFM Protocols. Moscow Experiences 1990-1992.
|
|
|
:
|
First Successes and Failures.- Improved Prognosis in ALL with Modified BFM Protocols-Preliminary Results from Turkey.- Long-Term Follow-Up of a Pilot Study of Intermittent Intensive Continuation Therapy (HL-3 Protocol) for Childhood Acute Lymphoblastic Leukemia.- Successful Central Nervous System Prophylaxis Without Radiotherapy in Childhood Acute Lymphoblastic Leukemia (ALL); Israel National Studies (INS 1984,1989).- Effect of Granulocyte Colony-Stimulating Factor After Intensive Consolidation Therapy on Relapsed Acute Lymphoblastic Leukemia in Children.- R-metHug-CSF Combined with Chemotherapy for Treatment of Adult ALL - Pilot Study.- Chemotherapy for Relapsed Childhood Acute Lymphoblastic Leukemia: Results of the BFM Study Group.- The Proliferative Activity of Blastic Cells in Acid-Phosphatase Positive Childhood Acute Lymphoblastic Leukemia (ALL).- Vertebral Compression Fractures in the Course of Acute Lymphoblastic Leukemia in Children.- Effect of Chemotherapy on Bone Marrow Granulocyte - Macrophage and Stormal Precursors in Children with ALL.- Influence of Corticosteroids on Coagulation Factors.- FAB Morphology and Prognosis in Childhood Acute Lymphoblastic Leukemia (ALL).- PCR as a Diagnostic Tool in ALL: A Comparison Between Cytogenetic and Polymerase Chain Reaction Analysis in Pediatric Patients with Acute Lymphoblastic Leukemia.- Prognostic Value of Hypoxanthine-Guanine Phosphoribosyl-Transferase in Childhood Leukemia.- ALL in Adults.- Cytogenetic Findings in Acute Lymphoblastic Leukemia.- Cancer and Leukemia Group B Studies in Acute Lymphoblastic Leukemia.- Adult Acute Lymphoblastic Leukemia - Results of the French AALL 87 Protocol with Different Strategies of Postremission Therapy.- Therapy of Adult Acute Lymphoblastic Leukemia. Preliminary Results of the GIMEMA ALL/0288 Study.- High-Dose Cytosine Arabinoside in the Treatment of Acute Lymphoblastic Leukaemia.- Myeloid Surface Antigen Expression in Adult Acute Lymphoblastic Leukemia.- Efficacy of an Original Cell Kinetics Based Chemotherapy Regimen Using rHU GM-CSF for Induction and Consolidation Treatment of ALL.
|
|
|
:
|
Preliminary Analysis.- Is Early Response to Chemotherapy a Useful Prognostic Factor in Adult Acute Lymphoblastic Leukemia?.- Analysis of BCR - ABL Rearrangement by PCR in Adult Acute Lymphoblastic Leukemia (ALL): A Report on 28 Cases.- AML in Children.- Preliminary Results of AML Therapy in Children Using Targeted Plasma Concentrations of Cytosine Arabinoside and Etoposide.- Early Intensive Chemotherapy for Children with Acute Myelogenous Leukemia: The Pediatric Oncology Group Experience (1981-1991).- Cranial Irradiation is Essential in the Treatment of Childhood Acute Myelogenous Leukemia: Results of Study AML-BFM-87.- Children's Cancer Group Transplant Trials for Acute Myeloid Leukemia in Children: ACross-Study Analysis of CCG-251, CCG-213, CCG-2861, and CCG-2891.- Six Months of Intensive Chemotherapy for Childhood ANLL: Preliminary Results of the Study ANLL-87 of the Dutch Childhood Leukemia Study Group.- Multidrug Resistance Reversal Utilizing Mitoxantrone, Etoposide and Continuous Infusion Cyclosporine in Pediatric ANLL.- Therapy of Acute Myelogenous Leukemia in Childhood - Results of the Multicenter Trial AML II/87 in East Germany.- Second Remission in Relapsed Childhood Acute Myelogenous Leukemia After Pretreatment with the AML-BFM83 Protocol.- Measles Giant Cell Pneumonia in Two Children with Acute Myeloid Leukemia.- AML in Adults.- Chemotherapy Intensity and Long-Term Outcome in AML.- Clinical Aspects of Acute Myelogenous Leukemias of the FAB-Types M3 and M4Eo.- Randomized Study of Intensive Individualized Induction Therapy With or Without Vincristine and of Maintenance/Intensification Therapy in Adult Acute Myeloid Leukemia.- Recruitment of Leukemia with Combined Granulocyte-Macrophage and Host Stimulatory Factors.- Clinical Trials in Adults with Acute Myelogenous Leukemia: Experience of the Eastern Cooperative Oncology Group.- Autologous Bone Marrow Transplantation in Acute Leukemia with Edelfosine Purged Marrow.- Prospective Study on the Clinical Relevance of Residual Disease in Patients with Acute Myeloid Leukemia in Complete Remission.- Results of AML Treatment.- AML in the Elderly.- A Multicenter Trial Randomizing Fractionated Aclacinomycin and Cytarabine with or without Etoposide versus "3 + 7" for Primary AML.- A 12-Year Follow-Up of 101 Patients with Acute Myeloid Leukemia Treated in Two Studies.- Idarubicin/Cytosine Arabinoside and Mitoxantrone/Etoposide with rhGM-CSF Priming for De Novo Acute Myelogenous Leukemia.- GM-CSF in a Double-Blind Randomized Placebo-Controlled Trial in Therapy of Adult Patients with De Novo Acute Myeloid Leukemia.- Significance of Prognostic Factors During an Idarubicin-Containing Regimen in Adult AML.- Myelodysplastic Remission in De Novo Acute Myeloid Leukemia: Implications for Early Relapse and Putative Monoclonal Remission.- Cytogenetic Findings Delineating Karyotypic Instability in Erythroleukemia Correlated with Bad Prognosis.- Presence of inv(16) May Be One of the Only "Favorable" Prognostic Factors in AML: A Report on 16 Cases.- ALL Transretinoic Acid Followed by Intensive Chemotherapy in Newly Diagnosed Acute Promyelocytic Leukemia: A Pilot Study on 27 Cases.- Therapy-Related Acute Promyelocytic Leukemia: A Report on 16 Cases.- Monosymptomatic Relapse of Acute Myeloid Leukemia Confined to the Skin.- MDS/Secondary AML.- Cytogenetics of Acute Leukemia Following MDS.- Thymidine Kinase Activity in Bone Marrow Cells as Basis for Rational Treatment of Myelodysplastic Syndromes.- Descriptive Epidemiology of Myelodysplastic Syndromes.- Myelodysplastic Syndromes: Response to Aggressive Chemotherapy and Prognostic Factors for Treatment Outcome.- Sequential Administration of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor and Human Erythropoietin for Treatment of Myelodysplastic Syndromes.- Bone Marrow Transplantation.- Bone Marrow Transplantation for Children with Acute Lymphoblastic Leukemia Failing Conventional Therapy.- Allogeneic Marrow Transplants in the Acute Leukemias.- Influence of Growth Suppression of Intestinal Bacteria on the Risk of Acute Graft vs Host Disease After Sibling Marrow Transplantation.- Autologous Bone Marrow Transplantation in Acute Myelocytic Leukemia in Europe: The Role of Marrow Purging.- IBMTR Analyses of Results of Bone Marrow Transplantation in Acute Leukemia.- Allogeneic Bone Marrow Transplantation in Patients with AML in First Complete Remission: Prognostic Factors for Survival?.- Comparison of High-Dose Busulfan and Total Body Irradiation Prior to Allogeneic Bone Marrow Transplantation.- Graft Rejection After Allogeneic Bone Marrow Transplantation: The Impact of T Cells, Graft-Versus-Host Reaction and Marrow Cell Number.- Continuous Intravenous Pentoxifylline in Bone Marrow Transplant Recipients: First Results of a Pilot Study.- Autologous Transplantation with Mafosfamide-Purged Bone Marrow for Acute Myelogenous Leukemia in First and Second Complete Remission.- Graft-Versus Leukemia Activity in Experimental Bone Marrow Transplantation: The Impact of Natural Killer Cells and Graft-Versus-Host Disease.- Fractionated Total Body Irradiation or Busulfan in Combination with Etoposide and Cyclophosphamide as Conditioning Regimen for Bone Marrow Transplantation in Acute Leukemias in Children.- Autologous and Allogeneic Bone Marrow Transplantation After Identical High-Dose Chemo-Radiotherapy in Children with Relapsed ALL.- Bone Marrow Transplantation from an Unrelated Donor: Experiences in Children.- Successful Adoptive Immunotransfers in a Boy with Relapse of T-ALL After Bone Marrow Transplantation from an Unrelated Donor.- Fluoroquinolones for Infection Prevention After Bone Marrow Transplantation.- Prevention and Treatment of Infections.- New Drugs for the Prevention and Treatment of Pneumocystis carinii Pneumonia.- Prevention of Bacterial Infection in Patients with Profound Granulocytopenia: Experience of the Institute Jules Bordet.- Interventional Antimicrobial Strategy for the Management of Infections in Neutropenic Patients with Hematologic Malignancies: Results of a Multi-Center Randomized Comparison of Antimicrobial Regiments.- Treatment of Fungal Infections.- Cancer and Leukemia Group B (CALGB) Studies with Hematopoietic Growth Factors in Patients with Acute Myeloid Leukemia.- Inhalation of Amphotericin B for Prophylaxis of Invasive Fungal Infections During Intensive Leukemia Therapy.- Infection.- Inhalation of Amphotericin B for Prophylaxis of Invasive Fungal Infections During Intensive Leukemia Therapy.- The Frequency of Bacterial and Fungal Infections in Acute Leukemia Types According to FAB Classification.- Once Daily Dosing of Netilmicin in the Empirical Treatment of Fever in the Neutropenic Patient.- Interventional Treatment of Unexplained Fever (FUO) and Documented Infections in Neutropenic Patients with Hematological Malignancies: Fluconazole vs Amphotericin B/5-Flucytosine.- Invasive Aspergillosis During Chemotherapy in Children.- Liposomal Amphotericin B (Ambisome) in Patients with Severe Neutropenia and Antibiotic Resistant Fever.- Efficacy of Liposomal Amphotericin B (AmBisome) in Neutropenic Patients with Fungal Infections.- Differential Cell Count and Lymphocyte Subsets of Bronchoalveolar Lavage in Patients with Severe Granulocytopenia.- Cytomegalovirus Infection in Children with Blood Malignancies and Aplastic Anemias.- Emerging Bacterial Pathogens in Patients with Acute Leukemia: Viridans Streptococci and Non-Fermentative Gram-Negative Bacilli.
|
| LC Classification
|
:
|
RB45.T383 2013
|
| Added Entry
|
:
|
B Wörmann
|
|
|
:
|
G Schellong
|
|
|
:
|
J Ritter
|
|
|
:
|
T Büchner
|
|
|
:
|
W Hiddemann
|
| |